LUPRODEX 11.25 INJ (3M)

About

Leuprolide acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer, endometriosis, central precocious puberty, and uterine fibroids. It works by initially stimulating and then desensitizing the GnRH receptors in the pituitary gland, leading to a profound and sustained suppression of gonadotropin release (LH and FSH). This suppression, in turn, reduces the production of sex hormones (testosterone in males, estrogen in females) to castrate levels.

The 3-month depot formulation provides continuous therapeutic levels, offering convenience and improved patient adherence for long-term management of hormone-dependent conditions. This sustained release helps maintain consistent hormone suppression, which is critical for the efficacy of treatment in these chronic conditions, reducing the frequency of injections for patients.

Uses

• Palliative treatment of advanced prostate cancer.
• Management of endometriosis.
• Treatment of central precocious puberty.
• Management of uterine fibroids.

Directions For Use

Administered as a subcutaneous or intramuscular injection every three months by a healthcare professional. Follow the prescribed schedule strictly.

Benefits

• Effective in hormone-dependent conditions.
• Convenient 3-month extended-release formulation.
• Reduces sex hormone levels significantly.
• Improves symptoms in prostate cancer and endometriosis.
• Delays puberty progression in central precocious puberty.
• Reduces uterine fibroid size and associated symptoms.

Side Effects

• Hot flashes
• Injection site reactions (pain, redness)
• Fatigue
• Headache
• Nausea
• Bone pain (initial flare in prostate cancer)
• Decreased libido
• Erectile dysfunction (males)
• Vaginal dryness (females)
• Mood changes
• Weight gain
• Osteoporosis (long-term use)

Safety Measures

• Alcohol - Alcohol does not directly interact with leuprolide, but it's generally advisable to maintain overall health during treatment.
• Pregnancy - Leuprolide is contraindicated in pregnancy due to its pharmacological effects on sex hormones and potential harm to the fetus.
• Breastfeeding - It is unknown if leuprolide is excreted in human milk. Breastfeeding is generally not recommended during treatment.
• Liver - Use with caution in patients with liver impairment. Close monitoring of liver function may be considered.
• Kidney - No specific dosage adjustment is typically required for patients with renal impairment.
• Lung - No specific precautions for lung conditions are typically noted for leuprolide.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.